8.1 NICE will support this guidance with a range of activities to promote the recommendations for further research. This will include incorporating the research recommendations in section 7 into the NICE guidance research recommendations database (available on the NICE website at www.nice.org.uk) and highlighting these recommendations to public research bodies. The research proposed will also be put forward to NICE's Medical Technologies Evaluation Programme research facilitation team for consideration of the development of specific research protocols.
8.2 The manufacturer has offered Oncotype DX to the NHS under a proposal (December 2012) that makes Oncotype DX available to the NHS at a revised price. The proposal price is commercial-in-confidence. It is the responsibility of the manufacturer to communicate details of the proposal to the relevant NHS organisations. Any enquiries from NHS organisations about the access proposal should be directed to Genomic Health UK at NHSOncotype@genomichealth.com or 020 3031 8087.